openPR Logo
Press release

Foot and Mouth Disease (FMD) Vaccines Market Future Lies In Oil-Based Vaccines, Expected To Reach US$0.95 bn by 2020

01-03-2017 02:26 PM CET | Health & Medicine

Press release from: Transparency Market Research - Pharmaceutical

Foot and Mouth Disease (FMD) Vaccines Market Future Lies

A new Transparency Market Research report states that the global foot and mouth disease (FMD) vaccines market was valued at US$0.51 bn in 2013 and is predicted to reach US$0.95 bn by 2020. The market is projected to expand at a CAGR of 8.80% from 2014 to 2019. The title of the report is “Foot and Mouth Disease Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020.”

rowse the full Foot and Mouth Disease Vaccines Market (Types- Conventional (Aluminum Hydroxide/Saponin and Oil Based Vaccines) and Emergency Vaccines; Application- Cattle, Pigs, Sheep and Goat and Others - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 report at http://www.transparencymarketresearch.com/foot-mouth-disease-vaccines.html




Foot and mouth disease (FMD) is a highly contagious disease and is caused by the virus called Aphthovirus from the family Picornaviridae. The virus can result in high fever for about two to six days, which is followed by blisters on the feet and inside of the mouth of the animal. This disease is infectious and can sometimes also prove fatal for animals. This viral disease is common in cloven-hoofed animals such as wild and domestic bovid.

As per the report, the rising consumption of dairy products and meat by humans is a key factor fuelling the market for foot and mouth disease vaccines. In addition, the increasing number of initiatives taken by governments globally is also augmenting the growth of the foot and mouth disease vaccines market. Furthermore, the prime growth opportunity in the market is the proliferation of DNA vaccines holding great potential in the cure of foot and mouth diseases in animals. On the other hand, the intervention of governments in vaccine purchasing has resulted in decreased costs of these vaccines, hence posing a negative impact on the growth of the market.

In terms of type, the report segments the market into emergency vaccines and conventional vaccines. The segment of conventional vaccines include aluminum hydroxide/ Saponin and oil-based vaccines. Amongst these, the demand for conventional vaccines is poised to rise in the coming years due to the rising adoption of routine vaccination strategy for controlling or eradicating the spread of foot and mouth disease. Amongst conventional vaccines, the segment of oil-based FMD vaccines held the largest share in the market in 2013.

The foot and mouth disease vaccines are used majorly on animals such as pigs, cattle, sheep and goats, and others. These vaccines can be also administered to certain species of deer, camels, and giraffe. Amongst these, the segment of cattle led the market in 2013 due to the rising presence of cattle globally. In addition, this segment is also fuelled by the increasing dependency of humans on animal proteins such as meat and milk globally.

In terms of geography, the market is segmented into Europe, North America, Asia Pacific, and Rest of the World (RoW). Amongst these, Asia Pacific holds the largest share in the market due to the presence of key FMD epidemic countries in this region. These countries are India, China, South Korea, Hong Kong, Bangladesh, and Pakistan. On the other hand, North America, majority of the Western European region, New Zealand, and Australia are FMD free, thus the growth of the market is predicted to be minor or nil within these regions and countries in the forecast horizon.

Bayer AG, Brilliant Bio Pharma Limited, Inova Biotechnologia, Intervac (Pvt.) Ltd., and Merck Animal Health (MSD), among others are the major players operating in the market, as per this report.

The global foot and mouth disease vaccines market is segmented as follows:

Global Foot and Mouth Disease Vaccines Market, by Types

Conventional Vaccines
Aluminum Hydroxide/Saponin
Oil Based
Emergency Vaccines
Global Foot and Mouth Disease Vaccines Market, by Applications

Cattle
Pigs
Sheep and Goats
Others
Global Foot and Mouth Disease Vaccines Market, by Geography

North America
Europe
Asia-Pacific
China
India
South Korea
Malaysia
Rest of APAC
Rest of the World
Latin America
Africa
South Africa
Algeria
Nigeria
Rest of Africa
Rest of RoW
Browse : Our new press releases http://www.transparencymarketresearch.com/pressrelease/global-foot-mouth-disease-vaccines.htm?

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr.Sudip S
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Foot and Mouth Disease (FMD) Vaccines Market Future Lies In Oil-Based Vaccines, Expected To Reach US$0.95 bn by 2020 here

News-ID: 404953 • Views:

More Releases from Transparency Market Research - Pharmaceutical

Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Neurovascular Devices Market Business Opportunities and Growth Challenges Report
Global Neurovascular Devices Market: Overview The global population is aging rapidly. According to WHO, the chances of health risks are greater in geriatric people than the young generation. Old age is considered to be one of the biggest risk factors that are responsible for developing various diseases such as cardiovascular and neurological conditions. It is because of these factors, the global neurovascular devices market is experiencing robust growth in the
Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2026
Pneumococcal Vaccines Market anticipated expand at a CAGR of 3.3% from 2018 to 2 …
Transparency Market Research (TMR) has published a new report titled, “Pneumococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global pneumococcal vaccines market was valued at US$ 7,247.6 Mn in 2017 and is anticipated expand at a CAGR of 3.3% from 2018 to 2026. Increase in patient pool, growth of the pharmaceutical industry, government initiatives to increase vaccination programs, rise
Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from 2020 to 2030
Swab and Viral Transport Medium Market projected to expand at a CAGR of ~3% from …
Swab and Viral Transport Medium Market: Introduction Transparency Market Research has published a new report titled, ‘Global Swab and Viral Transport Medium Market ’. According to the report, the global swab and viral transport medium market was valued at US$ 0.9 Bn in 2019 and is projected to expand at a CAGR of ~3% from 2020 to 2030. Viral transport medium (VTM) enables safe transfer of viruses, chlamydia, and mycoplasma for
Radiofrequency Ablation Devices Market by Product, Geography and Forecast to 202 …
Transparency Market Research (TMR) has published a new report titled, 'Radiofrequency Ablation Devices for Pain Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global radiofrequency ablation devices for pain management market was valued at US$ 543.0 Mn in 2018 and is projected to expand at a CAGR of above 11.0% from 2019 to 2027. Overview Radiofrequency ablation is a minimally invasive surgical

All 5 Releases


More Releases for Vaccines

Vaccines Market: Information by Type (Monovalent Vaccines, Multivalent Vaccines) …
Till date, vaccines have majorly contributed to eradicating several severe diseases—smallpox and polio—from the face of the earth. During 1980–90, around millions of people died due to smallpox. Moreover, after the introduction of a worldwide End Polio Campaign, the number of polio cases has reduced to 407 in 2013 from 350,000 in 1988, the CDC. Global vaccines market was valued at USD 30.2 billion in 2018 and is expected to
Global Pet Vaccine Market By Type (Attenuated Live Vaccines, Conjugate Vaccines, …
The Global Pet Vaccine Market 2020 report implement in-depth research of the industry with a focus on the current market trends future prospects. The Global Pet Vaccine Market report aims to provide an overview of Pet Vaccine Market players with detailed market segmentation by product, application and geographical region. It also provides market share and size, revenue forecast, growth opportunity. The most recent trending report Worldwide Pet Vaccine Market Economy
Animal Vaccines Market Report 2018: Segmentation by Product (Attenuated Vaccines …
Global Animal Vaccines market research report provides company profile for Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Anicon Labor GmbH, Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, Arko Laboratories, Ltd. Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in
Vaccines & Vaccination Market Report 2018: Segmentation by Type (Subunit vaccine …
Global Vaccines & Vaccination market research report provides company profile for CSL, Emergent BioSolutions, GSK, Johnson & Johnson, Pfizer, Merck, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,